Anzeige
Mehr »
Login
Freitag, 04.12.2020 Börsentäglich über 12.000 News von 648 internationalen Medien
+++Übernahmekampf: Hammer-Nachricht bei unserem Nevada-Goldwert+++
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von BioPharma-Reporter

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DoJanssen acquires rights to novel AMD gene therapy
DoLicensing deal set to enhance CRISPR/Cas libraries for target discovery and drug development
DoUK rolls out COVID-19 vaccine: Who gets the first doses?
DoMerck and Transcenta partner to advance continuous manufacturing for protein biotherapeutics
MiPreparing for the pivot to downstream continuous processing
MiAddressing barriers to the shift to downstream continuous processing
MiErbi Biosystems' platform is designed to support continuous processing, and startup flags its potential to transform CAR-T and other autologous therapies
MiPfizer and BioNTech COVID-19 vaccine authorized for use in the UK
DiJohnson & Johnson starts rolling review for COVID-19 vaccine in Europe
DiPfizer and Moderna apply for European COVID-19 vaccine authorization
DiAn experimental gene therapy may be effective for MND patients with a newly discovered genetic mutation
DiResearchers make 'exciting first step' to better understanding development and treatment of autism
MoSmall but mighty: Finnish company flags its nanoparticle technology as potential gamechanger for biologics sector
MoAre stable producer cells the future of viral vector manufacturing and when will allogeneic cell therapy take hold?
MoCould Pfizer's COVID-19 vaccine get the green light in the UK this week?
MoModerna submits EUA request for COVID-19 vaccine: "We believe our vaccine will provide a new and powerful tool that may change the course of this pandemic"
26.11.BioNTech & InstaDeep launch AI innovation lab for next-generation vaccines and biopharmaceuticals
26.11.BioInvent inks antibody manufacturing agreement with Cantargia
26.11.Compulsory licensing is not an effective policy tool, warns EU biopharma group as it reacts to European IP action plan
25.11.New EU pharma strategy looks to future-proof healthcare sector, stimulate innovation and boost access to biosimilars and generics
24.11.Transforming cold chain infrastructure: 'Ultra-cold smart container can transport all of the leading vaccine candidates for COVID-19'
24.11.Europe makes deal with Moderna for 160 million doses of COVID-19 vaccine
24.11.GlaxoSmithKline takes RSV maternal vaccine candidate into Phase 3 study
24.11.CureVac inks manufacturing deal with Wacker for its COVID-19 vaccine candidate
23.11.Merck to acquire Oncolmmune, accelerating development of COVID-19 treatment candidate